Apolipoprotein E (apoE) is associated with the two hallmarks of Alzheimer's disease: A␤ deposits and neurofibrillary tangles. ApoE synthesis was detected in astrocytes by in situ hybridization but was not detected in neurons. Nevertheless, different studies on apoE immunoreactivity reported the presence of apoE in neurons of Alzheimer, control, and necrosis pontisubicular brains. In this study, we addressed the question of potential synthesis of apoE in neurons and its possible involvement in or in response to pathological conditions. To this purpose, we have studied human neuronal cell lines (SY 5Y and Kelly cells) originating from neuroblastoma. Using monoclonal and polyclonal antibodies, a 32-kDa band was detected in SY 5Y and Kelly cells, before and after NGF differentiation. Twodimensional gel electrophoresis analysis showed a typical profile of apoE spots resolved to the exact isoelectric points. By reverse transcription-polymerase chain reaction experiments, we demonstrated the presence of apoE mRNA in these cell lines. SY 5Y cells synthesized the apoE3 variant, whereas Kelly cells expressed both apoE3 and apoE4 isoforms, corroborating the two-dimensional gel results. These results suggested that apoE synthesis could occur in human neuronal cell lines under certain conditions. 1997 Academic Press
INTRODUCTION
Apolipoprotein E (apoE) is the most abundant apolipoprotein in the human brain, which is the second major site of its synthesis (Elshourbagy et al., 1985) . ApoE exists as three major isoforms which differ from one another by the presence of a Cys or an Arg at the 112 and 158 AA positions (Weisgraber et al., 1981) . These isoforms are named E2 (Cys 112, Cys 158), E3 (Cys 112, Arg 158), and E4 (Arg 112, Arg 158).
In recent years, many reports have provided evidence of a potential role for apoE in Alzheimer's disease (AD). An increase of apoE mRNA was observed in astrocytes of AD brains (Diedrich et al., 1991) . Numerous genetic studies clearly demonstrated a modulation of the apoE effect according to the expressed alleles: the ⑀4 allele acts as a risk factor (Strittmatter et al., 1993; Saunders et al., 1993; Corder et al., 1993; Mayeux et al., 1993; Poirier et al., 1993) , whereas the ⑀2 allele may have a protective effect (Chartier-Harlin et al., 1994; Corder et al., 1994) . Immunohistochemical studies showed that apoE is present in the two neuropathological abnormalities characteristic of this disease: extracellular amyloid deposits and intracellular neurofibrillary tangles (Namba et al., 1991; Strittmatter et al., 1993) . Furthermore, allele ⑀4 may have an effect on the duration of the disease and on the amyloid deposits (Frisoni et al., 1995; Schmechel et al., 1993) .
In vitro studies have shown a possible direct interaction of apoE with the major component of both neuropathological markers of AD: A␤ peptide, the main component of amyloid deposits (Strittmatter et al., 1993; Wisniewski et al., 1994) ; and Tau proteins, the main constituent of the paired helical filaments, which are themselves assembled in neurofibrillary tangles (Strittmatter et al., 1994; Huang et al., 1995; Richey et al., 1995; Fleming et al., 1996; Ledesma et al., 1996) . These interactions are dependent on the apoE isoform and need the presence of apoE in extracellular space and within neurons. Thus, it is important to determine whether neurons are able to synthesize apoE. To date, apoE synthesis has been detected only in glial cells, in
